| Serial Number | 90302469 |
| Word Mark | NEXRETYS |
| Filing Date | Friday, November 6, 2020 |
| Status | 732 - THIRD EXTENSION - GRANTED |
| Status Date | Monday, July 22, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, December 13, 2022 |
| Goods and Services | Chemical pharmaceutical preparations in the nature of chemical preparations for pharmaceutical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; human medicines for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; biochemical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; pharmaceutical preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medicinal capsules for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical chemical preparations in the nature of chemical preparations for medical purposes for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical biological preparations for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical ointments, namely, medicated ointments for treating or preventing inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical drugs for the treatment or prevention of inflammatory disease, graft-versus-host disease, liver diseases, lung diseases, pancreatic diseases, intestinal disorders, nerve damage diseases, neurodegenerative diseases, systemic inflammatory response syndrome, sepsis, multiple organ dysfunction syndrome, and metabolic disorders; medical diagnostic preparations |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 6, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | EVIVE BIOTECHNOLOGY (SHANGHAI) LTD. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Shanghai 201207 CN |
| Party Name | EVIVE BIOTECHNOLOGY (SHANGHAI) LTD. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | SHANGHAI 201203 CN |
| Party Name | Generon (Shanghai) Corporation Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Shanghai 201203 CN |
| Event Date | Event Description |
| Wednesday, January 6, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, November 10, 2020 | NEW APPLICATION ENTERED |
| Thursday, September 30, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, April 14, 2021 | ASSIGNED TO EXAMINER |
| Friday, April 16, 2021 | PRIORITY ACTION WRITTEN |
| Friday, April 16, 2021 | PRIORITY ACTION E-MAILED |
| Friday, April 16, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Wednesday, June 16, 2021 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Thursday, September 30, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, October 1, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, April 20, 2022 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Monday, October 4, 2021 | SUSPENSION LETTER WRITTEN |
| Monday, October 4, 2021 | LETTER OF SUSPENSION E-MAILED |
| Monday, October 4, 2021 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, April 20, 2022 | SUSPENSION INQUIRY WRITTEN |
| Wednesday, April 20, 2022 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, November 8, 2022 | ASSIGNED TO LIE |
| Tuesday, May 31, 2022 | ASSIGNED TO EXAMINER |
| Monday, September 26, 2022 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, November 10, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 10, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 10, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 23, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 13, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 13, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 7, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, August 7, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, August 7, 2023 | SOU TEAS EXTENSION RECEIVED |
| Monday, August 7, 2023 | SOU EXTENSION 1 FILED |
| Monday, January 22, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, February 5, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, August 9, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, January 3, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, January 3, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, January 3, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, January 22, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Monday, January 22, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, February 5, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, February 5, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, February 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 23, 2024 | SOU EXTENSION 3 FILED |
| Tuesday, July 23, 2024 | SOU EXTENSION 3 GRANTED |
| Wednesday, July 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 22, 2024 | SOU TEAS EXTENSION RECEIVED |